https://scholars.lib.ntu.edu.tw/handle/123456789/568502
標題: | Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists | 作者: | Su J.-C. Chen K.-F. Chen W.-L. Liu C.-Y. Huang J.-W. Tai W.-T. PEI-JER CHEN Kim I. Shiau C.-W. |
關鍵字: | Cytotoxicity; Obatoclax; SHP-1; STAT3 | 公開日期: | 2012 | 出版社: | Elsevier Masson SAS | 卷: | 56 | 起(迄)頁: | 127-133 | 來源出版物: | European Journal of Medicinal Chemistry | 摘要: | Obatoclax is a linear oligopyrrole compound which antagonizes the antiapoptotic effects of the Bcl-2 family. Herein we describe the synthesis of obatoclax derivatives by replacement of the pyrrole and indole ring of obatoclax with thiophene, furan and thiazolidinedione. The in vitro cytotoxicity of the newly synthesized compounds is evaluated against hepatocellular carcinoma cells. Pyrrole and indole substituents of obatoclax analogues exhibited potent inhibition of cell growth. Among the tested compounds, 5d and 5e were active at 6.3 and 13.2 μM against PLC5 cells. Further assays confirmed a correlation between cell death, and p-STAT3 inhibition and SHP-1 activation by these analogues. ? 2012 Elsevier Masson SAS. All rights reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84984568875&doi=10.1016%2fj.ejmech.2012.08.024&partnerID=40&md5=49dac4db02d0db8e2e5a4d0e2afa659e https://scholars.lib.ntu.edu.tw/handle/123456789/568502 |
ISSN: | 0223-5234 | DOI: | 10.1016/j.ejmech.2012.08.024 | SDG/關鍵字: | 2 [2 [(1h pyrrol 2 yl)methylene] 3 methoxy 2h pyrrol 5 yl] 1h indol; 2 [2 [(1h pyrrol 2 yl)methylene] 3 methoxy 2h pyrrol 5 yl] 5 bromo 1h indol; 2,4 thiazolidinedione; antineoplastic agent; furan; indole; obatoclax; obatoclax derivative; protein tyrosine phosphatase SHP 1; pyrrole; STAT3 protein; thiophene; unclassified drug; article; biological activity; cancer cell; concentration response; controlled study; correlation coefficient; cytotoxicity; drug activity; drug potency; drug synthesis; enzyme activation; human; human tissue; in vitro study; liver cell carcinoma |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。